Driven by a passion for expanding patient access to innovative therapies, Dr. Ramesh Arjunji serves as executive vice president of value and access at Nanoscope Therapeutics. He has played a critical role in shaping strategies that connect scientific innovation with real-world impact. His cross-functional expertise spans commercial development, R&D, medical affairs, and business development in neurology, oncology, immunology, ophthalmology, metabolic diseases, and medical devices. 

Prior to joining Nanoscope, he served as Senior Vice President, Global Value and Access at Krystal Biotech, and earlier led evidence strategy as VP of Evidence Synthesis at SSI Strategy. Dr. Arjunji has also held executive and senior leadership roles at several other organizations, including AveXis/Novartis, Alcon, Biogen, Pfizer, and Centocor/J&J.

アルジュンジ博士は、テキサス大学ダラス校で経営科学の博士号、フロリダ州立大学で機械工学の修士号、インド工科大学カンプール校で航空学・航空宇宙科学技術の学士号を取得しました。.